Weigao Group Releases Overseas Regulatory Announcement on Subsidiary’s SSE Disclosure

Bulletin Express03-27

Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) has issued an overseas regulatory announcement pursuant to Rule 13.10B of the Hong Kong Stock Exchange Listing Rules.

The notice states that subsidiary Shandong Weigao Orthopaedic Device Company Limited has published an announcement on the Shanghai Stock Exchange website. No further details of the subsidiary’s disclosure are provided in the Hong Kong filing.

The Board of Weigao Group is chaired by Long Jing. Executive directors include Long Jing, Cong Rinan, Lu Junqiang and Wang Daoming. Non-executive directors are Chen Lin and Tang Zhengpeng, while the independent non-executive directors are Li Guohui, Meng Hong, Li Qiang and Sun Heng.

The overseas regulatory announcement was dated 27 March 2026 and released from Weihai, Shandong, the People’s Republic of China.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment